JAZZ · Jazz Pharmaceuticals plc · Documents
$227.76
-4.59 (-1.98%)
At close · Sep 30
Return incl. dividend (before tax)
Market Cap
$15.45B
Shares
64.91M
Volume · Sep 30
1.01M
Avg daily vol (3M)
862.33K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-09-23 | — | |
| 8-K | 2026-09-15 | — | |
| 8-K | 2026-08-31 | 2026-08-26 | |
| 8-K | 2026-08-25 | — | |
| 8-K | 2026-08-10 | — | |
| 8-K | 2026-08-10 | — | |
| 10-Q | 2026-08-03 | 2026-06-30 | |
| 8-K | 2026-08-03 | — | |
| 8-K | 2026-07-24 | 2026-07-23 | |
| DEF 14A | 2026-06-08 | 2026-07-23 | |
| Investor Event Transcript | 2026-06-03 | 2026-06-30 | |
| 8-K | 2026-05-29 | 2026-05-25 | |
| 10-Q | 2026-05-05 | 2026-03-31 | |
| 8-K | 2026-05-05 | — | |
| 10-K/A | 2026-04-24 | 2025-12-31 | |
| 10-K | 2026-02-24 | 2025-12-31 | |
| 8-K | 2026-02-24 | — | |
| 8-K | 2026-01-12 | — | |
| 8-K | 2025-11-17 | — | |
| 10-Q | 2025-11-05 | 2025-09-30 | |
| 8-K | 2025-11-05 | — | |
| 8-K | 2025-10-28 | 2025-10-23 | |
| 8-K | 2025-10-22 | 2025-10-21 | |
| 10-Q | 2025-08-06 | 2025-06-30 | |
| 8-K | 2025-08-05 | — | |
| 8-K | 2025-07-25 | 2025-07-24 | |
| 8-K | 2025-07-10 | 2025-07-08 | |
| DEF 14A | 2025-06-06 | 2025-07-24 | |
| 10-Q | 2025-05-07 | 2025-03-31 | |
| 8-K | 2025-05-06 | — | |
| 10-K/A | 2025-04-25 | 2024-12-31 | |
| 8-K | 2025-04-21 | — | |
| 8-K | 2025-04-08 | 2025-04-07 | |
| 8-K | 2025-03-05 | 2025-03-04 | |
| 8-K/A | 2025-03-05 | 2025-03-04 | |
| 10-K | 2025-02-26 | 2024-12-31 | |
| 8-K | 2025-02-25 | — | |
| 8-K | 2025-01-13 | — | |
| 8-K | 2024-12-16 | 2024-12-11 | |
| 8-K | 2024-11-26 | — | |
| 8-K | 2024-11-21 | 2024-11-20 | |
| 10-Q | 2024-11-07 | 2024-09-30 | |
| 8-K | 2024-11-06 | — | |
| 8-K | 2024-10-16 | 2024-10-10 | |
| 8-K | 2024-09-06 | 2024-09-03 | |
| 8-K | 2024-08-28 | 2024-08-27 | |
| 10-Q | 2024-08-01 | 2024-06-30 | |
| 8-K | 2024-07-31 | — | |
| 8-K | 2024-07-26 | 2024-07-25 | |
| 8-K | 2024-07-22 | 2024-07-19 |
Showing 1–50 of 135 filings
Key facts
CIK
1232524
CUSIP
G50871105
13F (30d)
15 filings
13 filers
Visit website
Investor relations